1. Home
  2. BSX vs GKOS Comparison

BSX vs GKOS Comparison

Compare BSX & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BSX
  • GKOS
  • Stock Information
  • Founded
  • BSX 1979
  • GKOS 1998
  • Country
  • BSX United States
  • GKOS United States
  • Employees
  • BSX N/A
  • GKOS N/A
  • Industry
  • BSX Medical/Dental Instruments
  • GKOS Medical/Dental Instruments
  • Sector
  • BSX Health Care
  • GKOS Health Care
  • Exchange
  • BSX Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • BSX 138.5B
  • GKOS 5.1B
  • IPO Year
  • BSX 1992
  • GKOS 2015
  • Fundamental
  • Price
  • BSX $95.12
  • GKOS $90.26
  • Analyst Decision
  • BSX Strong Buy
  • GKOS Strong Buy
  • Analyst Count
  • BSX 23
  • GKOS 13
  • Target Price
  • BSX $107.61
  • GKOS $155.00
  • AVG Volume (30 Days)
  • BSX 10.1M
  • GKOS 1.0M
  • Earning Date
  • BSX 04-23-2025
  • GKOS 04-30-2025
  • Dividend Yield
  • BSX N/A
  • GKOS N/A
  • EPS Growth
  • BSX 16.82
  • GKOS N/A
  • EPS
  • BSX 1.25
  • GKOS N/A
  • Revenue
  • BSX $16,747,000,000.00
  • GKOS $383,481,000.00
  • Revenue This Year
  • BSX $15.60
  • GKOS $27.84
  • Revenue Next Year
  • BSX $10.28
  • GKOS $27.99
  • P/E Ratio
  • BSX $76.10
  • GKOS N/A
  • Revenue Growth
  • BSX 17.61
  • GKOS 21.85
  • 52 Week Low
  • BSX $66.80
  • GKOS $77.91
  • 52 Week High
  • BSX $107.17
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • BSX 45.80
  • GKOS 41.57
  • Support Level
  • BSX $86.77
  • GKOS $86.16
  • Resistance Level
  • BSX $96.69
  • GKOS $94.55
  • Average True Range (ATR)
  • BSX 4.05
  • GKOS 6.54
  • MACD
  • BSX -0.02
  • GKOS 1.11
  • Stochastic Oscillator
  • BSX 59.74
  • GKOS 54.51

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: